[Prevalence and treatment for antibiotic-resistant bacteria in respiratory infection].
Watanuki
Yuji
Y
Department of Respiratory Medicine, Yokohama City University School of Medicine.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D006192:Haemophilus Infections / Q000188:drug therapy* / Q000382:microbiology*; D006193:Haemophilus influenzae / Q000235:genetics; D006801:Humans; D018942:Macrolides / Q000627:therapeutic use; D009154:Mutation; D010403:Penicillin Resistance / Q000235:genetics; D046915:Penicillin-Binding Proteins / Q000235:genetics; D011008:Pneumococcal Infections / Q000188:drug therapy* / Q000382:microbiology*; D015995:Prevalence; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000382:microbiology*; D015363:Quinolones / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology*; D013296:Streptococcus pneumoniae / Q000235:genetics; D018440:beta-Lactam Resistance / Q000235:genetics
D000900:Anti-Bacterial Agents; D018942:Macrolides; D046915:Penicillin-Binding Proteins; D015363:Quinolones